Upload
dragos-mirea
View
408
Download
0
Embed Size (px)
DESCRIPTION
A study aimed at offering new physical methods capable of highlighting the inflammatory stages of vascular and articular pathologies.
Citation preview
NANOPHYSICAL ANALYSIS TO STUDY EVOLUTION OF
VASCULAR AND ARTICULAR INFLAMMATORY PATHOLOGIES
Doctorant: MIREA Dragoş Alexandru
Directeurs de thèse:
BLANCHIN Marie-Geneviève - LPMCN
ŞABAN Rami - UPB
Co-encadrants:
TRUNFIO-SFARGHIU Ana-Maria - Lamcos, INSA Lyon
CIUCĂ Sorin - UPB
PlanGeneral introduction
Inflammatory pathologiesChosen strategies
Vascular pathologiesAtherosclerosisResults
Articular pathologiesOsteoarthritisResults
General discussion
2
General IntroductionInflammatory Pathologies
Vascularmortality 37% (2010)
Articularinvalidity 33% (2010)
Causes ? Only the risk factors are
known
HypertensionSmoking habitsAge
Patient's sexGenetically factorsHormonal factors
3
Presently medical treatments are available onlyin advanced stages of pathologies
Surgery Antalgic medicines
Prothesis implant surgeryNo synthetic synovial
fluid available(efficient as biolubricant)
restore blood flowtissue rupture risks
Detection of early inflammatory stage (vascular pathologies especially)
and follow up of subsequent stages of pathology evolution
Need for
Objectives
4
Testing new mimetics of antibodies to detect
vascular inflammatory markers
Correlating synovial fluid structure with rheological and tribological properties
RISKSDEATH INVALIDITY
New physical approaches to study the evolution of vascular and articularinflammatory pathologies
VASCULAR PATHOLOGIES ARTICULAR PATHOLOGIES
Measuring mechanical/elastic
properties of healthy and pathological
vascular tissues(what can improve surgical
gesture)
1V
2A2V
1A
Objectives for Vascular Pathologies
Objectives for Articular Pathologies
Improving knowledge ofsynovial fluid’s structure
5
Strategy1V
1A
2V
Measuring the affinity between antibodiesand inflammation markers
Measuring the affinity between different molecularcomponents of the synovial fluid
Measuring changes in elasticity of healthy or pathological vascular tissues
ELISA test can not : detect weak adhesion forcesbe used for lipids
Atomic Force Microscopy:Force Spectroscopy
Rheometric analysis:requires large and not ruguous samples
Atomic Force Microscopy:Indentation analysis
6
Strategy
2A Studying the rheological and tribological properties of synovial lubricant
Fluorescence RecoveryAfter Photobleaching (FRAP):
used to measure coefficient of diffusion of different
molecules with respect to other components
(towards rheological properties)
Tribological analysis:
used to determine friction coefficients between different fluid
componentsand lipids
(towards analysis of joint lubrication mechanism)
Atomic Force Microscopy – Force Spectroscopy
7
Principle
AFM functionalization techniques to determine interaction forces
Principle: Generating chemical interactions between free radicals from thesubstances of interest and the radicals from the cantilever binding
the substances to the cantilevers
8
Separator. Offers a higher freedomdegree to the linked molecules
AFM Force Spectroscopy to measure mechanical properties of biological samples
Calibration needed
9
Nanoindentation will be used here to determine the elastic properties of vascular tissues
Analytical models used to calculate the contact stress repartition
Hertz model
JKR model DMT model
Can be applied for very rigid materials for which elastic deformations are very low or in the lack of adhesion
10
The Hertz model with respect to indenter’s geometry
Data obtained in the experiments to determine the elastic modulus are usually several force-distance curves
The elastic modulus determined using equations specific to indenter’s geometry
11
Fluorescence Recovery After Photobleaching (FRAP)
12
Tribological Analysis
x
Moving table (v = 0.6 mm/s)
Fluorescence Microscope
Foucault sensor
Measurement of T
Normal load(NL = 2.5N)
Flexible lames
Flurescent Lipid
Bilayers
Hydrogel ~ few nm RMS
Glass0.2 nm RMS
13
Through a collaboration with B.Munteanu (Lamcos, INSA, Lyon)
Liquid environments
5mm
PlanGeneral introduction
Inflammatory pathologiesChosen strategies
Vascular pathologiesAtherosclerosisResults
Articular pathologiesOsteoarthritisResults
General discussion
14
Vascular PathologiesAtherosclerosis
I II IV V VIIII 5 mm
P-Selectin
15
MRI DetectionSurgical Treatment
Inflammatory marker
Targeting contrast agents to improve MRI detection
Inflammatory stage Plaque formation
Vascular PathologiesDetection of atherosclerosis through MRI using contrast
agents
Magnetic core
Polymeric coverAntibody
Collaboration with Cardiovascular Bioengineering
Laboratory (Inserm, U698), University Paris
7, F-75877, France
16
Antibody tested:Fucoidan - Mimetic of
PSGl-1 ligand of P-Selectin
F7200 and F50500 with different molecular
weights
AFM functionalization techniques to study interaction between Fucoidans and P-Selectin
AFM cantilever
ProteinsFucoidan
Glass substrateGlass substrate
P-Selectin
andBSA
17
Silanisation with APTES
CMA separatormolecule usedFucoidans
F7200F50500
AFM study of Fucoidan’s affinity for different proteins
AFM cantilever
Glass substrateGlass substrate
No adhesion AdhesionF7200and
F50500
P-SelectinandBSA
CMA control test 18
Experimental Procedure
Adhesion Peak
Microscope Veeco Multimode
Fucoidan Type Adhesion Force (nN) Adhesion percentage
1st seriesF7200
1st seriesF50500
2nd seriesF7200
2nd seriesF50500
3rd seriesF7200
3rd seriesF50500
0.05 43.89
0.08 61.33
CMABSA
P-SelectinCMA
BSAP-Selectin
CMABSA
P-SelectinCMA
BSA
P-SelectinCMA
BSAP-Selectin
BSAP-Selectin
0.05 99.01
0.07 91.98
0.06 74.580.08 97.05
0.11 32.670.06 44.49
0.29 100
0.31 100
0.33 100
0.22 24.790.28 47.22
0.47 95.66
0.21 23.36
0.05 43.890.08 61.33 19
Vascular inflammation: Affinity of Fucoidan for different proteins
Forces of adhesion between both Fucoidans and proteins are analyzed with respect to medium adhesion force in CMA control test
Noticeable differences appear between the 1st and 2nd series on one hand and the 3rd series of results on the other
hand The results may be considered as erratic due to low values in medium
adhesion force for P-Selectin with respect to CMA and BSA
Failure of purification process of Fucoidan?
Medium adhesion forces in control test are weakThe medium adhesion force values are lower in BSA with respect
to P-Selectin protein test
20
• Third series of experiments
Accounting for the fact that adhesion percentage for F7200 in third series was 96% this compound can be considered as a
good candidate to detect P-Selectin
• First and Second series of experiments
Study of mechanical properties for vascular tissues
AFM-FS was used to test the sample’s elasticity
Collaboration with the Department of Vascular andEndocrine Surgery, Hospital Henri Mondor, Rennes
Healthy and Pathologicalsamples of human aorta
affected by atherosclerosiswere obtained
Stored at -80°C immersed in DMSO 10%
21
Study of mechanical properties of vascular tissues
2 cm
5 mm
222 cm
Pathological and healthy vascular tissue harvesting
Experimental Procedure
AFM MicroscopePark Systems XE
70
SphericalIndenter
PyramidalIndenter
23
Study of mechanical properties of vascular tissues
24
Indentation in tissue determined from the force distance curves recorded by AFM
Elastic modulus of the tissues calculated using Hertz model’s equations
Force vs Indentation curves fitted with a simple power law: exponent
1.5 – spherical; 2 – pyramidal
From that fitting the correspondent elastic modulus was calculated
using equations according to the Hertz model
for example here,
Elastic modulus (MPa)Pathological tissue
Elastic modulus (MPa)
Healthy tissue
SphericalIndenter
PyramidalIndenter 3.4
0.9
0.55
0.11
2.7
1.7
1.1
Results
4.1
3.7
25
SphericalIndenter
Results and discussion
26
A higher elastic modulus is found for the healthy zones (in agreement with literature values) compared to the
pathological ones. Decrease in elasticity of pathological tissues is thought to be related to increase in adipose and calcification
Significant differences are obtained with the different types of indenters: This may be due to the large roughness and the 3D heterogeneity of the
samples.Friction forces between spherical indenter and samples may be
important and cause errors
Vascular: conclusions and perspectives
27
These results suggest that F7200 can successfully detect P-selectinwhile F50500 exhibits lower performances
Elastic moduli were calculated for both healthy and pathological tissue samples in agreement with literature values and consistent with influence of pathology
PlanGeneral introduction
Inflammatory pathologiesChosen strategies
Vascular pathologiesAtherosclerosisResults
Articular pathologiesOsteoarthritisResults
General discussion
28
Articular pathologies
29
Osteoarthritis is the most common joint disease affecting especially people aged over 55. It involves the whole joint and can be associated with cartilage
loss, changes in the subchondral bone and development of osteophytes.
Rheumatoid Arthritis is a complex autoimmune disease that causes chronicinflammation of synovial joints.
2 cm
Synovial joints
30
Remarkable tribological performances:
Life expectancy over 80 years!
Synovial fluid
Joint Implants2 cm
Many of the current treatmentsavailable are based on the partial
or total replacement of the synovialjoint by an artificial one
Current research is focused on
determination of synovial fluid’s structure to obtain a
more efficient artificial lubricant
Physiologic serum
+
Glucides:Hyaluronic Acid 3g/l
Proteines: Albumin 18 g/lGlobulin 2 g/l
Lipids 3 g/l
+
+
Molecular chain
L ~ 12 000 nm
Globular protein
8 nm3 nm
Glycoproteic gelAlbumin
Hyaluronic acid
2,5 nm
0,5 nm
Lipid bilayer
Oates K.M.N. et all, 2005
The Synovial Fluid
31
Composition of the Synovial Fluid
AFM cantileverCMA – a
“separator” in order to keep the
molecular configuration in
solution
1. Hyaluronic acid
2. Globular proteins (BSA, globulin )
8 nm3 nm
3. Lubricin
Substances of interest
5 nm
Lipid bilayer
Measurement of
intermolecular affinity
AFM methods to detect affinities between molecular components of the synovial fluid
Polyelectrolyte
Mimicked here by Mucin III or Proteo-Glycan 4
Lubricin
32
AFM functionalization techniques to study affinity between molecular components of the synovial
fluidAFM cantilever
ProteinsHyaluronic Acid
Mucin III, Proteo-Glycan 4,BSA andγ-Globulin 33
Silanisation with APTES
CMA separatormolecule used
Lipid bilayer deposition techniques
34
5 nm
Co-adsorption technique
DOPC
DLPC
0.5 nm
0.5 nm
2.5 nm
2 nm
Te
Langmuir-Blodgett technique
Vesicle burst technique
Experimental Procedure
35
AFM cantilever
5 nm
Lipid bilayer
Measurement of intermolecular
affinity
Affinity of the synovial fluid components for lipid bilayers measured from AFM force distance curves
Specific force versus distance curves recorded
Microscope Veeco Multimode
36
Functionalized
substance
Penetration percentage
Adhesion percentage
Medium Adhesion Force
(nN)
CMA
BSA
γ-Globulin
Hyaluronic Acid
Mucin III
CMA
BSA
γ-Globulin
Hyaluronic Acid
PG 4
0%
0%
0%
0%
0%
0%
0%
0%
21.54%
15.4%
9.14%
25.05%
23.67%
61.15%
82.85%
6.1%
19.8%
25.3%
67.62%
65.1%
0.21
0.31
0.32
1.45
0.58
0.18
0.36
0.23
1.06
0.56
ResultsF
irst
Se
ries
Se
con
d S
eri
es
36
Discussion
37
The seric proteins which exhibit low affinity for the lipid bilayers probably play a secondary role
The AFM study represents a static approach: a more “rheological” approach is needed to confirm these results
The results are analyzed in terms of adhesion force between substances of interest and lipid bilayers with respect to adhesion
force in CMA control test:Clearly Lubricin and Hyaluronic Acid exhibit the highest
affinities and are thought to play a key role
FRAP studies
38
Diffusion of the synovial fluid’s main components incubated on lipid bilayers was studied using FRAP techniques
Leica Confocal TSP3 microscope equipped with a 488nm line of the argon laser for photobleaching was used
The DLPC and DOPC lipid bilayers were deposited using both Langmuir-Blodgett (first series) and Vesicle burst (second series) techniques
The fluorescence of bilayers was obtained by addition of 1% NBDfluorescent molecules in the initial lipid solution
1mg/ml in PBS
0.25mg/ml
FRAP studies
2.5μm
50μm
ROI
Between 2 and 45 ROIs+ 1 Reference non-
bleached
5 nm
39
Diffusion coefficient
Displaced exponential law
Half-Life time
39
Results
40
Incubated substance of
interest
Number of measureme
nts
Diffusion coefficient
(cm2/s)
Immobile fraction
First series
DLPC 6 5.93 0.52DLPC + Mucin III 89 1.51 0.58
DLPC + Hyaluronic Acid 30 1.41 0.51DLPC + γ-Globulin 58 4.94 0.54
DLPC + BSA 55 4.56 0.59
Second series
DLPC 51 8.12 0.53DOPC 48 7.86 0.55
DOPC + Mucin III 89 2.77 0.52DOPC + Hyaluronic Acid 20 5.41 0.54
DOPC + γ-Globulin 527.41
0.51
DOPC + BSA 23 6.74 0.59
• 10
-9
40
Discussion
41
No dependence of diffusion coefficients on ROI dimension
Over the two series no significant difference in the diffusion coefficient values depending on lipid compound or bilayer deposition
technique, except in the case of Hyaluronic Acid whose diffusion coefficient remains lower
The substances that exhibit high affinity for the lipid bilayers as measured by AFM-Force Spectroscopy also exhibit here significantly
lower diffusion coefficients
Tribological Analysis
Normal pressure: 0.3 – 1 MPa (similar to knee)
Speed : 0.1 – 1 mm/s (no hydrodynamic phenomena)
x
Moving table (v = 0.6 mm/s)
Fluorescence
Microscope
Foucault sensor
Measurement of T
Normal load(NL = 2.5N)
Flexible lames
Flurescent Lipid
Bilayers
Hydrogel ~ few nm
RMS
Glass0.2 nm RMS
Friction coefficient (f) = T/N
42
1. Physiological serum salt
4. Lipid vesicles containing
glycoproteic gel
2. Lubricin solution 200 µg/ml
3. Glycoproteic gel: solution HA
3mg/ml + BSA 18mg/ml + Globulin 2mg/ml
Through a collaboration with B.Munteanu (Lamcos, INSA, Lyon)
Tribological resultsLubricant Fluorescence
microscopyFriction
coefficientVelocity
accommodation
43
0.008
0.035
0.1
0.008
80μm
Physiological salt
solution
Lubricinsolution
Glycoproteicgel
Lipid vesicles
LubricinCartilage
Hyaluronic acid + seric
proteins
Lipid layers
Hyaluronic acid (HA)High affinity for lipidSeric proteins – low
adhesion lipid and reticulation with HA
glycoproteic gelCOF non included glycoproteic
gel COF glycoproteic gel included
HA and seric proteins
remain inside the vesicles
44
lipid multilamellar
vesicles0.1µ
m
VOLUME
Presence of lipid
multilamellar layers
Hills A.B., Internal Medicine
Journal 2002
INTERFACE
Lubricin- adhesion and
COF on lipid- adhesion on cartilage (Rhee D.K.,
2005)
Lubricin fixes the
lipid layers on
the cartilage
Articular Pathologies: conclusions and perspectives
Trunfio-Sfarghiu A.M, and all. BiomMedD'2008
PlanGeneral introduction
Inflammatory pathologiesChosen strategies
Vascular pathologiesAtherosclerosisResults
Articular pathologiesOsteoarthritisResults
General discussion
45
46
General Discussion, Conclusions and Perspectives
Vascular pathologies
Fucoidan F7200
Fucoidan F50500
Positive results for F7200 to detect P-Selectin inflammatory marker
Testing new antibody mimetics to detectP-Selectin inflammatory marker
Collaboration with Cardiovascular Bioengineering Laboratory (Inserm, U698), University Paris 7, F-75877, France
Measuring elasticity for pathological and healthy vascular tissues
Collaboration with Department of Vascular and Endocrine Surgery from Hospital Henri Mondor, Rennes & Lamcos, INSA, Lyon, France
This study may help reduce the risk of vascular tissue rupture during angioplasty surgery
Noticeable differences for elastic modulus values between healthy and pathological tissue samples
Further tests repeated about ability of F7200 to detect P-, E-,
L-Selectin proteins
47
General Discussion, Conclusions and Perspectives
Articular pathologies
AFM - Measuring molecular
affinities between synovial fluid’s
components
Identification of possible key components for the synovial structure
FRAP – Studying the diffusion of different components incubated
on lipid substrates(towards rheological properties)
Tribological test performed to understand the role of these different components in joint lubrication
Towards optimization of artificial synovial fluids
3D model proposed for synovial fluid’s volume structure
Thank you for your attention!
I would like to give thanks to all everybody from LPMCN and UPB, you might not notice it but your
help was decisive for me, Thank-You !
Also I have reserved special thanks to my colleagues and everybody else, especially Ana-Maria et Mr. Berthier from Lamcos, INSA, Lyon and also to the team from Laboratoire Inserm, Paris, Thank-You!
And last but not least, to all of my friends here, Bogdan, Ionut, Livia, Ana, Liliana, Mihai, Antonio
andTo all of my coleagues Jose, Arnaud, Samuel, Lucas,
Clement, Guido, Dimitri, Lauri, Alejandro, Tomita, Marilena, Na et Simon
Thank-You !